← Back to Search

Group1 for Post-meal Blood Sugar Response

N/A
Waitlist Available
Led By Heather J Blewett, PhD
Research Sponsored by St. Boniface Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Generally healthy male or female, between the age of 18-40 years;
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 24 hours following a meal
Awards & highlights

Study Summary

This trial will test the effect of 3 types of peas on post-meal blood sugar and insulin levels, as well as appetite and any side effects.

Who is the study for?
This trial is for generally healthy men and women aged 18-40, with a BMI of 18.5-34.5 kg/m2, and normal blood sugar levels (HbA1c <6.0%). Participants must be willing to give informed consent and follow the study's requirements.Check my eligibility
What is being tested?
The trial aims to see how three types of peas affect blood sugar and insulin levels after meals in a controlled setting where participants switch between diets including peas or starchy foods like rice or potatoes.See study design
What are the potential side effects?
Potential side effects may include gastrointestinal discomfort due to high fiber content in peas. The study will also monitor how much participants like the food and any changes in appetite.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 40 years old and generally healthy.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 2 hours following a meal
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 2 hours following a meal for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Postprandial blood glucose
Postprandial blood insulin
Secondary outcome measures
Desire to eat (Visual analogue scales)
Fullness (Visual analogue scales)
Hunger (Visual analogue scales)
Other outcome measures
Acceptability of test products based on sensory scales
Gastrointestinal side effects

Trial Design

10Treatment groups
Experimental Treatment
Placebo Group
Group I: RiceExperimental Treatment1 Intervention
Group 1, Visit 2-5 Rice (equal to 50g available carbohydrate) given as breakfast to fasting participants
Group II: PotatoExperimental Treatment1 Intervention
Group2, Visit 2-5 Potato (equal to 50g available carbohydrate) given as breakfast to fasting participants
Group III: Pea variety 3 with riceExperimental Treatment1 Intervention
Group 1, Visit 2-5 Pea variety 3 with rice (25g available carbohydrate of each) given as breakfast to fasting participants
Group IV: Pea variety 3 with potatoExperimental Treatment1 Intervention
Group 2, Visit 2-5 Pea variety 3 with potato (25g available carbohydrate of each) given as breakfast to fasting participants
Group V: Pea variety 2 with riceExperimental Treatment1 Intervention
Group 1, Visit 2-5 Pea variety 2 with rice (25g available carbohydrate of each) given as breakfast to fasting participants
Group VI: Pea variety 2 with potatoExperimental Treatment1 Intervention
Group 2, Visit 2-5 Pea variety 2 with potato (25g available carbohydrate of each) given as breakfast to fasting participants
Group VII: Pea variety 1 with riceExperimental Treatment1 Intervention
Group 1,Visit 2-5 Pea variety 1 with rice (25g available carbohydrate of each) given as breakfast to fasting participants
Group VIII: Pea variety 1 with potatoExperimental Treatment1 Intervention
Group 2, Visit 2-5 Pea variety 1 with potato (25g available carbohydrate of each) given as breakfast to fasting participants
Group IX: White bread 1Placebo Group2 Interventions
Groups 1 and 2, Visit 1 White bread (equal to 50g available carbohydrate) given to fasting participant
Group X: White bread 2Placebo Group2 Interventions
Groups 1 and 2, Visit 6 White bread (equal to 50g available carbohydrate) given to fasting participant

Find a Location

Who is running the clinical trial?

Agriculture and Agri-Food CanadaOTHER_GOV
33 Previous Clinical Trials
2,241 Total Patients Enrolled
St. Boniface HospitalLead Sponsor
51 Previous Clinical Trials
11,545 Total Patients Enrolled
Heather J Blewett, PhDPrincipal InvestigatorAgriculture and Agri-Food Canada
2 Previous Clinical Trials
122 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any remaining vacancies in this clinical trial for participants?

"Unfortunately, this clinical trial is not actively seeking participants. Although the study was initially posted on October 16th 2015 and last updated on October 24th 2022, two other studies are presently open to enrolment."

Answered by AI

Is this research study open to patients who are younger than fifty years old?

"The age range for candidates hoping to participate in this research is between 18 and 40 years old."

Answered by AI

Could I qualify to participate in this research?

"This trial is seeking 64 individuals whose post-prandial glucose response aligns with the criteria of this study. To be considered, applicants must identify as either male or female and between 18 to 40 years old. Additionally, they should possess a BMI index between 18.5 to 34.5 kg/m2 and commit to fulfilling all study requirements."

Answered by AI
~7 spots leftby Apr 2025